Alto Capital Launches Cohesys SPV, an Early Stage Medtech Startup

Alto, an alternative asset platform that enables individuals to invest in alternative assets using both retirement and non-retirement funds, has launched the Cohesys SPV through Alto Capital, a wholly-owned subsidiary. The Cohesys SPV will be listed on Alto Marketplace, offering accredited investors a distinctive early-stage investment opportunity.
 
“At Cohesys, we are on a mission to change the trajectory of surgical bone repair through a cost-effective and potentially time-saving approach that aims to be a first of its kind in the orthopedic surgery market,” said Dr. Michael Floros, CEO of Cohesys. “We feel this partnership is truly authentic as both Alto and Cohesys are committed to providing customers with unique, high-quality products and services. This is a clear achievement that spans across multiple industries to potentially impact many in a positive way.”
 
Individual accredited investors can invest with Cohesys in its earliest days as it navigates clinical trials and early customer adoption to be involved from the beginning in an inspiring medtech company poised to enter a period of rapid growth. 
 
“It is an exciting partnership to raise capital for Cohesys, as they have identified an impressive opportunity to simplify orthopedic surgeries and potentially improve patient recovery through their product, BoneTape,” said Scott Harrigan, President of Alto and CEO of Alto Securities. “We are excited to list the Alto Capital Cohesys SPV on the Alto Marketplace, as we are giving accredited investors access to the compelling $30 billion orthopedic surgery market via an early-stage medtech company operating in the space.”